4.7 Article

Protective effects of grape seed proanthocyanidins on cardiovascular remodeling in DOCA-salt hypertension rats

Journal

JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Volume 26, Issue 8, Pages 841-849

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jnutbio.2015.03.007

Keywords

Grape seed proanthocyanidins; DOCA-salt hypertension; Cardiovascular remodeling; Antioxidant; p38; JNK

Funding

  1. PhD Programs Foundation of Ministry of Education of China [20103420120002]
  2. Anhui Medical University Foundation for Middle-aged and Young Scientist Leaders of Disciplines in Science [201324]
  3. National Natural Science Foundation of China [81073088, 81373774]

Ask authors/readers for more resources

Cardiovascular remodeling, as a hallmark of hypertension-induced pathophysiology, causes substantial cardiovascular morbidity and mortality. There is increasing evidence that has demonstrated a broad spectrum of pharmacological and therapeutic benefits of grape seed proanthocyanidins (GSP) against oxidative stress and cardiovascular diseases. In this study, 180- to 200-g SD rats treated with DOCA (120 mg/week sc with 1% NaCl and 02% KCl in drinking water) and GSP (150, 240, 384 mg/kg) or amlodipine (ALM) (5 mg/kg) for 4 weeks were recruited. The protective effects of GSP on blood pressure and cardiovascular remodeling in rats with DOCA-salt-induced hypertension were investigated. Our results indicated that DOCA-salt could induce hypertension, cardiovascular remodeling and dysfunction, oxidative stress and the release of endothelin-1 (ET-1) and could increase JNK1/2 and p38MAPK phosphorylation. GSP or ALM treatments significantly improved hypertension, cardiovascular remodeling and dysfunction and oxidative stress, restrained the release of ET-1 and down-regulated the JNK1/2 and p38MAPK phosphorylation. These findings demonstrate that GSP has protective effects against increase of blood pressure induced by DOCA-salt hypertension and cardiovascular remodeling by inhibiting the reactive oxygen species/mitogen-activated protein kinase pathway via restraining the release of ET-1. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available